Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Denali unveil proof-of-concept data for brain delivery tech in rare disease, with eyes on much bigger indications
5 years ago
R&D
George Church and an entrepreneurial postdoc join the hunt for AAV 2.0 with a new vector-cloaking technology
5 years ago
Startups
Cell/Gene Tx
Roche touts less onerous schedule for its in-the-eye injection faricimab, hoping to sweeten the sales pitch over ...
5 years ago
R&D
Covid-19 roundup: Fauci says first graders could have access to vaccine by September — report; EMA begins rolling ...
5 years ago
Coronavirus
Eli Lilly strips ousted CFO Josh Smiley of $24M in pay after 'inappropriate messages' scandal
5 years ago
People
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and ...
5 years ago
Pharma
Amicus shares slammed as lead PhIII drug fails a key head-to-head test for Pompe disease — but the CEO still ...
5 years ago
R&D
FDA+
Regeneron antibody earns nod for rare cholesterol disorder — but it ain't cheap
5 years ago
FDA+
Wading deeper into target discovery and validation, Immunai bags $60M to beef up both AI algorithms and lab benches
5 years ago
Financing
AI
Vigene Biosciences goes big on Maryland viral vector expansion as it rides high on Altimmune vaccine deal
5 years ago
Manufacturing
Endpoints Manufacturing: Lonza drops ingredients biz in $4.7B sale; Touchlight's 'doggyboneDNA' looks to rewrite ...
5 years ago
Manufacturing
Germany's Rentschler looks to build UK footprint with five-year investment in cell and gene therapies
5 years ago
Deals
Manufacturing
Quotient, buoyed by Covid-19 work, buys Arcinova in effort to build end-to-end CDMO brand
5 years ago
Deals
Manufacturing
With crossover round in its pocket, synthetic lethality-focused Cyteir Therapeutics eyes a jump onto Nasdaq
5 years ago
Financing
Exscientia to collaborate with Oxford's Alzheimer's center; Dana-Farber enlists Repertoire for head and neck cancer
5 years ago
News Briefing
Bristol Myers takes next big gamble on I/O frontier, pledging nearly $1.4B on Texas firm's tumor toxins
5 years ago
Deals
Dyno sketches tens of thousands of viable next-gen AAV capsids with the help of machine learning — paper
5 years ago
AI
Cell/Gene Tx
AC Immune has 'remarkable' Alzheimer's vaccine data. Just don't ask to see them
5 years ago
R&D
Novartis' Sandoz splurges on a trio of GSK antibiotics, doubling down with a $500M bet on a field struggling to ...
5 years ago
Deals
All in on ide-cel, Bristol Myers Squibb writes off $470M as second BCMA CAR-T is ejected from the pipeline
5 years ago
R&D
Fresenius Kabi pays $50 million to settle criminal charges
5 years ago
FDA+
Manufacturing
Versant spinout lands $80M to go 'much broader' than the old Roche partnership that birthed it
5 years ago
Financing
India's TCG launches new CDMO arm stateside to meet the call for 'American-made' pandemic drugs
5 years ago
Manufacturing
Novo Nordisk's blockbuster diabetes drug blows the doors off in obesity, proving highly effective in driving weight ...
5 years ago
R&D
First page
Previous page
735
736
737
738
739
740
741
Next page
Last page